VCOB yields 1.08% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VCOB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCOB + MRK for your $10,000?
VCOB is an actively managed ETF seeking current income and capital appreciation. It invests in investment grade debt such as corporate, government, and mortgage-related bonds, including both US and foreign, including emerging market issuers. The portfolio may also include derivatives like options, futures, and swaps for hedging, tactical asset allocation, or enhancing returns. The fund typically maintains a dollar-weighted average duration between 3 and 10 years, based on interest rate changes. The investment process combines macroeconomic, top-down, insights with detailed bottom-up analysis, considering factors like sector allocation, security selection, and yield curve positioning. Proprietary research, quantitative analytics, and scenario-based risk testing guide investment decisions, including ESG criteria as one of multiple factors. High portfolio turnover is expected, as the management actively buys and sells holdings to capture gains, limit losses, or pursue new opportunities.
Full VCOB Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.